Skip to main content

Review Articles

 

Clinical courses

 

Clinical research courses

  • FLUORIDE ADULTERATION IN DENTAL PRODUCTS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Nidha Amir*, Mohd Mazhar, Abhinav Sawhney, S.K Rajput
    Department of Pharmacology
    Amity Institute of Pharmacy, Amity University, NOIDA, Uttar Pradesh-201313, India
    nidha.amir05@gmail.com

    ABSTRACT
    Fluorine, the 13th most abundant element of the earth’s crust, represents about 0.3g / kg of earth’s crust. It occurs mainly in the form of chemical compounds such as sodium fluoride or hydrogen fluoride, which are present in minerals fluorospar, fluorapatite, topaz and cryolitect. Fluoride is frequently encountered in minerals and in geochemical deposits and is generally released into subsoil water sources by slow natural degradation of fluorine contained in rocks. Fluoride being a natural element has several effects on health. Fluoride is beneficial to health if the concentration (CF) of the fluoride ion (F-) in drinking water is less than 1.5 mg/L (WHO 1994). A higher concentration causes serious health hazards. The disease caused manifests itself in three forms, namely, dental, skeletal, and non-skeletal fluorosis. On a large scale, it is used in dental product due to its anti- sensitizing property and abrasive action. Application of fluoride must be controlled and restricted to reduce the side effect induced by it.

  • AN OVERVIEW ON BENZOTHIAZINONE ANALOGS AS ANTITUBERCULAR DRUGS

    { DOWNLOAD AS PDF }

    ABOUT AUTHOR:
    Mohammad Asif
    Department of Pharmacy, GRD(PG) Institute of Management & Technology,
    Dehradun, (Uttarakhand), 248009, India
    aasif321@gmail.com

    ABSTRACT:
    The reappearance of tuberculosis and the rush of multidrug-resistant clinical isolates of Mycobacterium tuberculosis have reaffirmed tuberculosis as a key public health concern. Describe findings on the pharmacological status of Benzothiazinones as new agents that are being developed as antitubercular drugs. Benzothiazinones act by targeting the enzymes responsible for the formation of arabinans that are essential parts of the cell wall. In view of their novel mechanism of action, these drugs appear promising as anti-TB drugs and considered to be promising candidates for future development.

  • RESOURCES, GUIDANCE, CONTROL AND PREVENTION FOR EBOLA VIRUS DISEASE-AN OVERVIEW

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Jadhav Santosh1*, Mali Audumbar1, Tamboli Ashpak2
    Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade, Sangola-413307, Solapur, Maharashtra, India1.
    Department of Pharmaceutical chemistry, Sahyadri College of Pharmacy, Methwade, Sangola-413307, Solapur, Maharashtra, India2.
    jadhavsan88@gmail.com*

    ABSTRACT
    Since the current Ebola Virus Disease (also referred to as Ebola Haemorrhagic Fever) outbreak began in Guinea in December of 2013, the outbreak now involves trans-mission in Guinea, Liberia, Nigeria, and Sierra Leone. Ebola haemorrhagic fever (EHF) is a zoonosis affecting both human and non-human primates (NHP). Ebola virus (formerly officially designated Zaire Ebolavirus, or EBOV) was first seen infecting humans in African continent; especially  Sudan, Democratic Republican of Congo, Zaire and nearby countries. Fruit bats of the Pteropodidae family are considered to be the natural host of the Ebola virus. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The World Health Organization (WHO) reports that this is the largest Ebola Virus Disease (EVD) outbreak ever recorded. EVD outbreaks have a case fatality rate ofup to 90%. The research is on-going on development of making vaccine to curb this virus yet licensed success or specific treatment is not achieved.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • A REVIEW ON DYSLEXIA

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    S.Ramyasilpa
    Department of pharmacology,
    Nargund college of pharmacy, Bengaluru
    shilpasankarapu@gmail.com

    ABSTRACT
    Dyslexia is a specific reading disorder. It is common childhood disorder affecting around 5% of school aged children. The main deficits of dyslexia include inability to process sensory input (i.e., acoustic information) that comes into the nervous system rapidly, and an impaired reading ability. Secondary consequences may include problems in reading comprehension and reduced reading experience that can impede growth of vocabulary and background knowledge. The dyslexia is associated with alteration of several biological levels like genetic, biochemical, physiological, cognitive levels.

    (adsbygoogle = window.adsbygoogle || []).push({});
  • CLINICAL PHARMACY IN INDIA: RECENT ADVANCES AND PERSPECTIVE

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Mazhar M1, Ansari. A2, Rajput SK1*
    1Department of Pharmacology, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh-201313.
    2Department of Social Work, University Road, University of Delhi, Delhi-110007.
    *skrajput95@amity.edu

    ABSTRACT
    In lieu of the fact that without adequate supervision, the assurance of quality of any system is not possible; clinical pharmacy has emerged as one of the latest and unmapped discipline of pharmacy in the 21st century. The existence of clinical pharmacists in medical rounds could support physicians in optimizing pharmacotherapy. This novel profession in India extends its diversions to good manufacturing practices, procurement/preparation/distribution of medication, reporting ADRs/ ADEs and on the whole to a very promising aspect of patient healthcare service. The state of clinical pharmacy in India is in the transformational state showing serious positive promising changes in the past couple of years. Even hospitals have started distinguishing the importance of clinical pharmacy and have taken initiatives for making it possible although at a budding stage. The clinical pharmacy branch of pharmacy is surely attaining new heights in regard to patient care services which have certainly increased the services and satisfaction to the patients.

  • CHILDHOOD OBESITY: REASON BEHIND THIS HEALTH CRISIS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Abhinav Sawhney*, Nidha Amir, Mohd Mazhar, Sumeet Gullaiya, Satyendra K Rajput
    Department of Pharmacology,
    Amity institute of Pharmacy, Amity University,
    Noida, Uttar Pradesh
    abhinavsawhney@live.com

    ABSTRACT:
    Obesity has emerged as a major health issues for pediatric population as well as in adults in the present global scenario. In children, numerous studies have reveiled a relationship between the breast feeding and obesity in children. Apart from these, Family economic and education level, child meal pattern, duration of sleep and birth weight are also responsible for obesity. Some genetic problems including environmental and socio-economic factors are also responsible for the child obesity. Several studies have shown an evidence of protective effect of breast feeding against obesity while some shows a time dependent effect of breast feeding on childhood obesity. As per WHO recommendations, a child should be exclusively breast fed upto 6 months and breast fed along with the complementary food of good quality.  Introduction of the complementary food has a relationship bound with adipose rebound, which goes upto the age of 14. The intake of complementary food reduces the intake of breast milk and also induces the allergic reactions in the child. Apart from these leptin level and energy regulation in the body also plays and important role in pediatric obesity.

  • SYSTEMATIC APPROACH FOR COMPLAINT HANDLING IN PHARMACEUTICAL INDUSTRIES- AN UPDATED REVIEW

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Jadhav Santosh*, Mali Audumbar, Bathe Ritesh, Tamboli Ashpak, Sawale Jyotiram
    Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade,
    Sangola, Solapur, Maharashtra, India.
    *jadhavsan88@gmail.com

    ABSTRACT:
    This article covers fundamental basics of quality complaint.Complaints show customer dissatisfaction about the quality of a pharmaceutical Product. Complaints may be about: Services, delivery, quality of product, communication, response time, documentation, billing, follow up etc. a good complaint handling system gives the company an opportunity to improve the quality of their products, being a good tool for the maintenance of Good Manufacturing Practices. A systematic procedure must be developed and implemented in order to register and investigate each complaint received and not only the Quality Assurance area must be involved. Systematic handling of complaints maintains a good relationship between customer and company. Thus the aim of this article is to discuss the main steps of a good complaint handling procedure that can be readily implemented in pharmaceutical companies.

  • CHRONOPHARMACOTHERAPY OF HYPERTENSION: TIME-DEPENDENT EFFECTS OF TREATMENT ON BLOOD PRESSURE

    { DOWNLOAD AS PDF }

    ABOUT AUHTORS:
    Suresh Rewar1*, Bansal BK1, Singh CJ2, Sharma AK2
    1Department of pharmaceutics, Arya College of Pharmacy, Jaipur, Rajasthan India
    2Department Of Pharmacology, Arya College of Pharmacy, Jaipur, Rajasthan India
    sureshrewar1990@gmail.com

    ABSTRACT
    Chronopharmaceutical drug delivery systems are gaining a lot of interest as they deliver the drug at the right site of action, right time and right amount, as per the pathophysiological needs of the diseases. These systems are basically time-controlled drug delivery systems in which the system controls the lag time independent of environmental factors like pH, enzymes, GIT motility, etc. These systems are designed for chronopharmacotherapy which is based on the circadian rhythm of the body. The effectiveness and toxicity of many drugs vary depending on dosing time associated with 24 hr. rhythms of biochemical, physiological and behavioral processes under the control of circadian clock. The chronobiology of the various common 24-hour BP profiles seen in hypertensive patients in relation to cardiovascular risk and end-organ injury and ultimately the control and normalization of abnormal BP throughout daytime activity and night time sleep. Chronopharmacotherapy provides a means of individualizing the treatment of hypertension according to the circadian BP profile of each patient, and constitutes a new option to optimize BP control and to reduce the risk of cardiovascular disease. Various latest and upcoming marketed technologies of Chronopharmaceutical drug delivery used in treatment of hypertension diseases like OROS®, CODAS®, CEFORM®, DIFFUCAPS®, PULSINCAP® etc.

  • REVIEW: PLAGIARISM AN ACT OF UNETHICS

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Anuradha Sharma1*, Vaibhav Walia2, Monika Gahlawat3
    1Division of Pharma. Chemistry, 2Division of Pharmacology, 3Division of Pharmaceutics,
    G.V.M. College of Pharmacy,
    Sonepat, Haryana, India
    *anusarswat@gmail.com

    ABSTRACT
    Plagiarism is a multifaceted and ethically a complex problemwhich simply means the stealing and publication of another author’s work as one's own original work without acknowledge the original author. Plagiarism is simply an act of fraud.Authors should acknowledge sources fully and appropriately to follow the ethics and plagiarism is failure to do so. However the students or the authors sometimes fail to acknowledge the source appropriately and properly. These failures are largely due to the lack of knowledge to use the citations properly. Therefore to maintain the ethics the plagiarism should be avoided. The aim of this paper is to define plagiarism, its type, methods of detection and the ways to avoid plagiarism.

  • A REVIEW ON ROLE OF LASER PHOTOCOAGULATION THERAPY IN DIABETIC RETINOPATHY

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    M. Sushma*, T. V. V. Vidyadhar, M. Babu M.D., R. Mohan raj
    *Department of Pharmacy Practice,
    Raghavendra Institute of Pharmaceutical Education & Research, RIPER.
    K R Palli Cross, Near S.K University, Anantapuramu District, Andhra Pradesh
    sushma.banthi@gmail.com

    ABSTRACT
    Diabetic retinopathy, one of the leading causes of blindness for diabetic patients between the ages of 20 and 74. The clinical research provides control of blood glucose and blood pressure substantially reduces the risk of blindness due to diabetic retinopathy, many patients develop this eye disease and are at risk for serious vision loss, sometimes even despite outstanding metabolic control. Diabetic retinopathy occurs when high blood glucose damages the micro blood vessels in the retina which leads to leakage of small amounts of blood, serum, blood fats and blood proteins proliferates to vision loss and formation of scar tissue. Here the retinal laser therapy also called aslaser photocoagulation has greatly reduced the number of patients who lose vision to Diabetic retinopathy. Laser photocoagulation refers to the precise and concentrated application of high energy light, typically of a single wavelength called monochromatic light.

Subscribe to Review Articles